Collateral Global is a UK registered Charity (No. 1195125) dedicated to researching, understanding, and communicating the effectiveness and collateral impacts of the Mandated Non-Pharmaceutical Interventions (MNPIs) taken by governments worldwide in response to the COVID-19 pandemic.

For more information, see our FAQs page.

Why Collateral Global

Utilizing the enduring principles of scientific inquiry, we aim to provide scholarship and research, building an evidence-based understanding of mitigation measures that is both accessible and actionable.

Our Vision, Mission, & Strategy

Our Vision: A world where pandemic policy responses maximise health and well-being for all.
Our Mission: Cultivating a better understanding of the impact of the COVID-19 responses.
Our Strategy: To collate, review, and analyse the evidence; to assess the impact of measures taken across the globe; to communicate with clarity, compassion and objectivity.


We are funded by donations from those who support our mission and vision. We are not dependent on any single funding source and maintain complete editorial and scientific independence from our contributors. Read more about how CG is funded here.

Our Contributors

Our contributors come from all over the world and represent a range of lived experiences, professions, and ideologies. Articles can be published anonymously where requested; CG keeps all contributors’ names on a confidential database. In case of anonymised publication, we will only release data to third parties where the contributor has consented.

Get Involved

Visit our Get Involved page to learn more about how you can support Collateral Global’s mission.

Who We Are

Collateral Global is made up of an international and collaborative community of academics, health professionals, and citizens who document, study, and communicate the collateral effects of the measures taken by governments to mitigate the damage of the COVID-19 pandemic.

  • Alex Caccia

    Alex Caccia

    CG Governing Board CEO, Collateral Global
  • Professor Jay Bhattacharya

    Professor Jay Bhattacharya

    CG Scientific Advisory & Editorial Boards Professor of Medicine, Stanford University & CG Editor-in-Chief
  • Professor Sunetra Gupta

    Professor Sunetra Gupta

    CG Scientific Advisory Board Professor of Theoretical Epidemiology at the Department of Zoology, University of Oxford
  • Professor Carl Heneghan

    Professor Carl Heneghan

    CG Scientific Advisory Board Professor of Evidence-Based Medicine & Director of Centre for Evidence-Based Medicine, University of Oxford
  • Professor Paul Dolan

    Professor Paul Dolan

    CG Scientific Advisory Board Professor of Behavioural Science, London School of Economics
  • Professor Ellen Townsend

    Professor Ellen Townsend

    CG Scientific Advisory Board Professor of Psychology, University of Nottingham
  • Professor Toby Green

    Professor Toby Green

    CG Scientific Advisory Board Professor of African History, King's College, London
  • Dr Alberto Giubilini

    Dr Alberto Giubilini

    CG Editorial Board Philosopher & Senior Research Fellow in Practical Ethics, University of Oxford

Our Values


The scientific method determines our approach. Theory has to answer to evidence while ensuring the conceptual framework, sources, and methods are declared and clear.


Care for people drives us. Disease, suffering, and death are part of the human condition, and we should all support each other to minimise harm. We are not interested in accusation and blame.


We have faith and belief in human ingenuity to find better solutions, grasp the nettle, and establish good outcomes grounded in reality.

Get Involved

Support the Collateral Global project by contributing news and research, donating, signing up for our newsletter, or sharing us on social media.